SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001072613-03-000226
Filing Date
2003-02-12
Accepted
2003-02-12 11:52:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A - COLLAGENEX PHARMACEUTICALS INC. sch13g_11714k.txt SC 13G/A 11326
  Complete submission text file 0001072613-03-000226.txt   13320
Mailing Address 3801 KENNETT PIKE SUITE B 107 WILMINGTON DE 19807
Business Address 3801 KENNETT PIKE SUITE B 107 WILMINGTON DE 19807 3026551750
ASHFORD CAPITAL MANAGEMENT INC (Filed by) CIK: 0000897070 (see all company filings)

IRS No.: 510243208 | State of Incorp.: DE | Fiscal Year End: 0930

Mailing Address 41 UNIVERSITY DRIVE NEWTON PA 18940
Business Address 41 UNIVERSITY DRIVE NEWTON PA 18940 2155797388
COLLAGENEX PHARMACEUTICALS INC (Subject) CIK: 0001012270 (see all company filings)

IRS No.: 521758016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-47825 | Film No.: 03553086
SIC: 2834 Pharmaceutical Preparations